Pharmacogenetics for Pain Management in Joint Replacement Patients
NCT ID: NCT03772535
Last Updated: 2021-02-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
50 participants
INTERVENTIONAL
2018-12-03
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pharmacogenomics Information in Enhancing Post-operative Total Joint Replacement Pain Management: a Pilot Study
NCT02711592
How Variations in Pharmacogenomic Profiles Affect Pain and Narcotic Needs Following Total Knee Arthroplasty (TKA)
NCT04020471
Improving Pain Management and Long Term Outcomes Following High Energy Orthopedic Trauma (Pain Study)
NCT01789216
Implementing Genomics in Practice (IGNITE): CYP2D6 Genotype-Guided Pain Management in Patients Undergoing Arthroplasty Surgery
NCT03534063
Dexketoprofen and Etoricoxib in Patients Undergoing Hip Arthroplasty
NCT02568735
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Subjects in this arm will receive the standard postoperative pain prescription protocol.
No interventions assigned to this group
Pharmacogenomics Guided Group
Subjects in this group will receive postoperative pain prescriptions based on the results of pharmacogenomic testing.
Pharmacogenomics Testing
The doctor will use genetic test results to prescribe medications that are a most effective for subject.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pharmacogenomics Testing
The doctor will use genetic test results to prescribe medications that are a most effective for subject.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Anderson Orthopaedic Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Hamilton, MD
Role: PRINCIPAL_INVESTIGATOR
Anderson Orthopaedic Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Anderson Orthopaedic Research Institute
Alexandria, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AORI 2018-0100
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.